Suppr超能文献

DNA双链断裂修复基因中的常见单核苷酸多态性与乳腺癌风险

Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.

作者信息

Pooley Karen A, Baynes Caroline, Driver Kristy E, Tyrer Jonathan, Azzato Elizabeth M, Pharoah Paul D P, Easton Douglas F, Ponder Bruce A J, Dunning Alison M

机构信息

Cancer Research UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, United Kingdom.

出版信息

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3482-9. doi: 10.1158/1055-9965.EPI-08-0594.

Abstract

The proteins involved in homologous recombination are instrumental in the error-free repair of dsDNA breakages, and common germ-line variations in these genes are, therefore, potential candidates for involvement in breast cancer development and progression. We carried out a search for common, low-penetrance susceptibility alleles by tagging the common variation in 13 genes in this pathway in a two-stage case-control study. We genotyped 100 single-nucleotide polymorphisms (SNP), tagging the 655 common SNPs in these genes, in up to 4,470 cases and 4,560 controls from the SEARCH study. None of these tagging SNPs was associated with breast cancer risk, with the exception of XRCC2 rs3218536, R188H, which showed some evidence of a protective association for the rare allele [per allele odds ratio, 0.89; 95% confidence intervals (95% CI), 0.80-0.99; P trend = 0.03]. Further analyses showed that this effect was confined to a risk of progesterone receptor positive tumors (per rare allele odds ratio, 0.78; 95% CI, 0.66-0.91; P trend = 0.002). Several other SNPs also showed receptor status-specific susceptibility and evidence of roles in long-term survival, with the rare allele of BRIP1 rs2191249 showing evidence of association with a poorer prognosis (hazard ratio per minor allele, 1.20; 95% CI, 1.07-1.36; P trend = 0.002). In summary, there was little evidence of breast cancer susceptibility with any of the SNPs studied, but larger studies would be needed to confirm subgroup effects.

摘要

参与同源重组的蛋白质有助于双链DNA断裂的无差错修复,因此,这些基因中常见的种系变异有可能参与乳腺癌的发生和发展。在一项两阶段病例对照研究中,我们通过标记该途径中13个基因的常见变异,寻找常见的低外显率易感等位基因。我们对SEARCH研究中多达4470例病例和4560例对照进行了100个单核苷酸多态性(SNP)的基因分型,这些SNP标记了这些基因中的655个常见SNP。除了XRCC2 rs3218536(R188H)外,这些标记SNP均与乳腺癌风险无关,该SNP的罕见等位基因显示出一定的保护关联证据[每个等位基因优势比为0.89;95%置信区间(95%CI)为0.80 - 0.99;P趋势 = 0.03]。进一步分析表明,这种效应仅限于孕激素受体阳性肿瘤的风险(每个罕见等位基因优势比为0.78;95%CI为0.66 - 0.91;P趋势 = 0.002)。其他几个SNP也显示出受体状态特异性易感性以及在长期生存中的作用证据,BRIP1 rs2191249的罕见等位基因显示出与较差预后相关的证据(每个次要等位基因风险比为1.20;95%CI为1.07 - 1.36;P趋势 = 0.002)。总之,在所研究的任何SNP中,几乎没有证据表明与乳腺癌易感性相关,但需要更大规模的研究来证实亚组效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验